Dr. Calum A. Macrae

Dr. Calum Archibald MacRae is Vice Chair for Scientific Innovation in the Department of Medicine at Brigham and Women’s Hospital (BWH), a Professor of Medicine at Harvard Medical School, and an expert member of BWH’s Cardiovascular Genetics Program, which comprehensively evaluates, diagnoses and manages care for inherited cardiac disorder patients. In addition, he is a leading investigator at the BWH Genomics Center and an associate professor of medicine at Harvard Medical School.He received his medical degree from University of Edinburgh College of Medicine. He completed two internal medicine residency programs: one at Wellcome Trust Centre for Neuroimaging in London and the other at BWH. He then completed a fellowship in cardiovascular disease at Massachusetts General Hospital. Dr. MacRae is board certified in internal medicine and cardiovascular disease.Dr. MacRae is a cardiologist and geneticist whose clinical interests include investigating new phenotypes and how research findings—including genomics discoveries—can be systematically implemented into clinical care. His research focuses on the biology and genomics of cardiovascular disease, specifically the biological basis of different arrhythmia susceptibilities. He holds five patents, has authored over 160 peer-reviewed publications and received research funding from the National Institutes of Health’s National Human Genome Research Institute.

Dr. Macrae is rated as an Advanced provider by MediFind in the treatment of Subvalvular Aortic Stenosis. His top areas of expertise are Cardiomyopathy, Familial Hypertrophic Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Dilated Cardiomyopathy (DCM), and Cardiac Ablation.

His clinical research consists of co-authoring 210 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.